SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTD
Overview
SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 4 active FDA Type II Drug Master Files, covering DEGARELIX ACETATE; LINACLOTIDE; LIRAGLUTIDE; SEMAGLUTIDE.
Core services & business areas
Active pharmaceutical ingredients supplied
Substances SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTD holds 6 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- THYMALFASINActive2026-06-29
- TIRZEPATIDEActive2026-06-29
- LIRAGLUTIDEActive2026-02-09
- DEGARELIX ACETATEActive2025-12-16
- LINACLOTIDEActive2025-09-23
- SEMAGLUTIDEActive2023-03-27
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.